Rotenberg, O., Doulaveris, G., Goldberg, G. L., Renz, M., Whitney, K., Dar, L., Rotenberg, N., Wu, H., Van den Bosch, T., & Dar, P. (2024). Combining Ultrasonography and Endometrial Aspiration as a One-Stop Screening for Endometrial Neoplasia. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000005752

Thimm-Kaiser, M., Whalen, A. M., Lui, M., Furuya, A., & Zadey, S. (2024). Associations of life course obesity with endometrial cancer: could alternative categorization of BMI change improve inference about cumulative risks? International Journal of Epidemiology, 53(5). https://doi.org/10.1093/ije/dyae120

Matsuo, K., Chen, L., Klar, M., Lee, M. W., Machida, H., Mikami, M., Muderspach, L. I., Carlson, J. W., Roman, L. D., & Wright, J. D. (2024). Prognostic performance of the 2023 FIGO staging schema for endometrial cancer. Gynecologic Oncology, 187, 37–45. https://doi.org/10.1016/j.ygyno.2024.04.016

Levin, G., Wright, J. D., Burke, Y. Z., Hamilton, K. M., & Meyer, R. (2024). Utilization and Surgical Outcomes of Sentinel Lymph Node Biopsy for Endometrial Intraepithelial Neoplasia. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000005637

Suzuki, Y., Ferris, J. S., Chen, L., Dioun, S., Usseglio, J., Matsuo, K., Xu, X., Hershman, D. L., & Wright, J. D. (2024). Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis. JNCI: Journal of the National Cancer Institute, 116(5), 653–664. https://doi.org/10.1093/jnci/djae023

Matsuo, K., Chen, L., Neuman, M. K., Klar, M., Carlson, J. W., Roman, L. D., & Wright, J. D. (2024). Lymph Node Isolated Tumor Cells in Patients With Endometrial Cancer. JAMA Network Open, 7(3), e240988. https://doi.org/10.1001/jamanetworkopen.2024.0988

Matsuo, K., Chen, L., Neuman, M. K., Klar, M., Roman, L. D., & Wright, J. D. (2024). Low-grade endometrioid endometrial cancer with adnexal only metastasis: Evaluation of de-escalation of adjuvant therapy. European Journal of Cancer, 113533. https://doi.org/10.1016/j.ejca.2024.113533

Dioun, S., Chen, L., De Meritens, A. B., St. Clair, C. M., Hou, J. Y., Khoury-Collado, F., Pua, T., Hershman, D. L., & Wright, J. D. (2024). Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapy. Gynecologic Oncology, 182, 70–74. https://doi.org/10.1016/j.ygyno.2023.12.027

Sereda, Y., Alarid-Escudero, F., Bickell, N. A., Chang, S.-H., Colditz, G. A., Hur, C., Jalal, H., Myers, E. R., Layne, T. M., Wang, S.-Y., Yeh, J. M., Trikalinos, T. A., Sereda, Y., Alarid-Escudero, F., Bickell, N. A., Chang, S.-H., Colditz, G. A., Hur, C., … Jalal, H. (2023). Approaches to developing de novo cancer population models to examine questions about cancer and race in bladder, gastric, and endometrial cancer and multiple myeloma: the Cancer Intervention and Surveillance Modeling Network incubator program. JNCI Monographs, 2023(62), 219–230. https://doi.org/10.1093/jncimonographs/lgad021

Whelan, K., Dillon, M., Strickland, K. C., Pothuri, B., Bae-Jump, V., Borden, L. E., Thaker, P. H., Haight, P., Arend, R. C., Ko, E., Jackson, A. L., Corr, B. R., Ayoola-Adeola, M., Wright, J. D., Podwika, S., Smitherman, C., Thomas, S., Lightfoot, M., Newton, M., … Alvarez Secord, A. (2023). TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes. Gynecologic Oncology, 178, 44–53. https://doi.org/10.1016/j.ygyno.2023.09.009

Sleiman, J., Farha, N., Beard, J., Bena, J., Morrison, S., Milicia, S., Heald, B., Kalady, M. F., Church, J., Liska, D., Mankaney, G., & Burke, C. A. (2023). Incidence and prevalence of advanced colorectal neoplasia in Lynch syndrome. Gastrointestinal Endoscopy, 98(3), 412-419.e8. https://doi.org/10.1016/j.gie.2023.04.001

Matsuo, K., Ciesielski, K. M., Mandelbaum, R. S., Lee, M. W., Jooya, N. D., Roman, L. D., & Wright, J. D. (2023). Lymph node evaluation for endometrial hyperplasia: a nationwide analysis of minimally invasive hysterectomy in the ambulatory setting. Surgical Endoscopy, 37(8), 6163–6171. https://doi.org/10.1007/s00464-023-10081-2

Rimel, B. J., Crane, E. K., Hou, J., Nakayama, J., MacDonald, J., Lutz, K., Makker, V., & O’Cearbhaill, R. E. (2023). Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations. Gynecologic Oncology, 174, 148–156. https://doi.org/10.1016/j.ygyno.2023.05.007

Momeni-Boroujeni, A., Vanderbilt, C., Yousefi, E., Abu-Rustum, N. R., Aghajanian, C., Soslow, R. A., Ellenson, L. H., Weigelt, B., & Murali, R. (2023). Landscape of chromatin remodeling gene alterations in endometrial carcinoma. Gynecologic Oncology, 172, 54–64. https://doi.org/10.1016/j.ygyno.2023.03.010

Violette, C. J., Agarwal, R., Mandelbaum, R. S., González, J. L., Hong, K. M., Roman, L. D., Klar, M., Wright, J. D., Paulson, R. J., Obermair, A., & Matsuo, K. (2023). The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research. Expert Review of Anticancer Therapy, 23(4), 385–395. https://doi.org/10.1080/14737140.2023.2194636

Boone, R. M., Praiss, A. M., Huang, Y., Melamed, A., Khoury-Collado, F., Hou, J. Y., Gockley, A., St. Clair, C. M., Hershman, D. L., & Wright, J. D. (2023). Heterogeneity of outcomes of endometrial cancer patients included in prospective clinical trials. Gynecologic Oncology, 169, 70–77. https://doi.org/10.1016/j.ygyno.2022.11.022

Jorgensen, K., Meernik, C., Wu, C.-F., Murphy, C. C., Baker, V. L., Jarmon, P., Brady, P. C., Nitecki, R., Nichols, H. B., & Rauh-Hain, J. A. (2023). Disparities in Fertility-Sparing Treatment and Use of Assisted Reproductive Technology After a Diagnosis of Cervical, Ovarian, or Endometrial Cancer. Obstetrics & Gynecology, 141(2), 341–353. https://doi.org/10.1097/aog.0000000000005044

Karia, P. S., Huang, Y., Tehranifar, P., Wright, J. D., & Genkinger, J. M. (2023). Racial and ethnic differences in type II endometrial cancer mortality outcomes: The contribution of sociodemographic, clinicopathologic, and treatment factors. Gynecologic Oncology, 168, 119–126. https://doi.org/10.1016/j.ygyno.2022.11.015

Dioun, S., Chen, L., Melamed, A., Gockley, A., St. Clair, C. M., Hou, J. Y., Khoury‐Collado, F., Hur, C., Elkin, E., Accordino, M., Hershman, D. L., & Wright, J. D. (2022). Dostarlimab for recurrent mismatch repair‐deficient endometrial cancer: A cost‐effectiveness study. BJOG: An International Journal of Obstetrics & Gynaecology, 130(2), 214–221. Portico. https://doi.org/10.1111/1471-0528.17338

Guo, X. M., Roman, L. D., Klar, M., Wright, J. D., & Matsuo, K. (2022). Malignant peritoneal cytology in endometrial cancer: a contemporary review. Expert Review of Anticancer Therapy, 22(9), 947–955. https://doi.org/10.1080/14737140.2022.2105208

Marsh, L. A., Aviki, E. M., Wright, J. D., Chen, L., Abu-Rustum, N., & Salani, R. (2022). Sentinel lymph node mapping for endometrial cancer: Opportunity for medical waste reform. Gynecologic Oncology, 166(1), 162–164. https://doi.org/10.1016/j.ygyno.2022.05.008

Bose, S., Schwartz, G. K., & Ingham, M. (2022). Novel Therapeutics in the Treatment of Uterine Sarcoma. American Society of Clinical Oncology Educational Book, 42, 900–909. https://doi.org/10.1200/edbk_350541

Matsuo, K., Klar, M., Nusbaum, D. J., Hasanov, M. F., Vallejo, A., Ciesielski, K. M., Muderspach, L. I., Roman, L. D., & Wright, J. D. (2022). Utilization and Outcomes of Sentinel Lymph Node Biopsy for Early Endometrial Cancer. Obstetrics & Gynecology, 139(5), 809–820. https://doi.org/10.1097/aog.0000000000004733

Matsuo, K., Khetan, V. U., Brunette, L. L., Jooya, N. D., Klar, M., Wright, J. D., & Roman, L. D. (2022). Characterizing isolated tumor cells in regional lymph nodes of early endometrial cancer. Gynecologic Oncology, 165(2), 264–269. https://doi.org/10.1016/j.ygyno.2022.02.015

Chin, C., & Damast, S. (2022). Radiation therapy in the definitive management of medically inoperable endometrial cancer. International Journal of Gynecological Cancer, 32(3), 323–331. https://doi.org/10.1136/ijgc-2021-002532